Armata Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARMP research report →
Companywww.armatapharma.com
Armata Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.
- CEO
- Deborah L. Birx
- IPO
- 1994
- Employees
- 60
- HQ
- Marina del Rey, CA, US
Price Chart
Valuation
- Market Cap
- $302.86M
- P/E
- -1.07
- P/S
- 102.39
- P/B
- -0.97
- EV/EBITDA
- -4.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 72.18%
- Op Margin
- -1258.55%
- Net Margin
- -9554.23%
- ROE
- 162.59%
- ROIC
- -57.13%
Growth & Income
- Revenue
- $4.90M · -5.22%
- Net Income
- $-173,799,000 · -818.79%
- EPS
- $-4.80 · -823.08%
- Op Income
- $-31,222,000
- FCF YoY
- 33.29%
Performance & Tape
- 52W High
- $16.34
- 52W Low
- $1.74
- 50D MA
- $10.19
- 200D MA
- $6.68
- Beta
- 1.32
- Avg Volume
- 60.32K
Get TickerSpark's AI analysis on ARMP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 24, 26 | Gilmer Daniel B. | other | 51,280 |
| Apr 24, 26 | Gilmer Daniel B. | other | 0 |
| Mar 14, 26 | Kyme Pierre | other | 1,030 |
| Mar 14, 26 | Birx Deborah | other | 4,919 |
| Mar 9, 26 | Kramer Robin | other | 25,640 |
| Mar 9, 26 | Kyme Pierre | other | 183,142 |
| Mar 9, 26 | House David Duane | other | 109,885 |
| Mar 9, 26 | PATTI JOSEPH M | other | 25,640 |
| Mar 9, 26 | Peterson Todd C. | other | 25,640 |
| Mar 9, 26 | Odysseas Kostas D | other | 25,640 |
Our ARMP Coverage
We haven't published any research on ARMP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ARMP Report →